Bermuda Celebrates Economic Ties with UK and U.S. and Highlights Strengths at London Forum
The strong and historic economic, political and cultural ties that exist between Bermuda, the UK and the U.S. set the scene for the Bermuda Executive Forum, held at the JW Marriott Grosvenor House London.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191127005410/en/
The opening keynote speakers at the Bermuda Executive Forum London 2019: (from left to right) Roland Andy Burrows, CEO of the BDA, The Hon. David Burt, JP, MP, Premier, Government of Bermuda, Fiona Luck, Non-Executive Director, Lloyd’s of London Franchise Board, Robert Wood Johnson, Ambassador of the United States of America to the United Kingdom of Great Britain and Northern Ireland and The Rt. Hon. Sir Nicholas Soames, Former Conservative Member of Parliament (Photo: Business Wire)
Under the theme ‘Navigating Disruption for Positive Change’, the U.S. Ambassador to the UK, Robert Wood Johnson, the UK’s Sir Nicholas Soames, former Conservative Member of Parliament, and Bermuda Premier, the Hon. E. David Burt, JP, MP, started the day with a wide-ranging conversation that touched on geopolitics, technology, digital disinformation, the need for lifetime education and how the solid relationship between the three countries becomes even more important during the current climate of change.
Premier David Burt said: “We had a fascinating panel with our friends from the UK and the U.S., demonstrating the importance of the relationship and the value Bermuda has to offer the global marketplace, including our ability to adapt quickly to change and keep pace with the times. This event provides an excellent platform for us to speak directly with prospective businesses and investors based in London and to spread the word about Bermuda. For those who are serious about raising capital in a well-regulated and well-respected jurisdiction, and deploying it in the most efficient manner possible, Bermuda is the place for you.”
Sir Nicholas referred to the triangle of Bermuda, the UK and the U.S. as an important force for good and highlighted how Bermuda continues to punch above its weight in the world while Ambassador Johnson expressed his admiration for how successful Bermuda has been as a small but beautiful island and how it continues to play a leading role in many areas.
Moderated by Fiona Luck, Non-Executive Director for the Lloyds of London Franchise Board and a Bermuda (re)insurance industry expert, the opening conversation was a highlight of an agenda packed with informative panels outlining global trends and showcasing the Bermuda market’s strengths across a range of industries—from re/insurance and asset management to trusts, family offices and fintech, as well as networking opportunities.
More than 130 business leaders and investors attended the event with a team of Bermuda representatives from across government, industry and the regulatory authority. The forum was the seventh in a successful series hosted by the Bermuda Business Development Agency (BDA) in cities of strategic importance to the Island, including New York, Toronto and Miami.
Roland Andy Burrows, CEO of the BDA, said: “London is an important market to Bermuda, so hosting this event has been incredibly valuable as we look to encourage further direct investment to the Island. It has been a successful day, allowing us an opportunity to engage with existing and new business partners. It’s evident our markets share many commonalities which bodes well for the future and, despite the current political backdrop in the UK, the level of participation and interest in Bermuda remains strong.”
The forum’s lunchtime keynote was Paul Gillen, Managing Director, Security Operations and Intelligence at Barclays and previously head of operations at Europol’s European Cybercrime Centre. He delivered an engaging talk, sharing insights into the spectrum of impacts and the global reach of cyber threats, as well as the ways in which proactive strategies and efforts continue to serve businesses well in protecting themselves across industries.
Numerous business development meetings and introductions took place on the sidelines of the event, which concluded with a networking reception followed by the Bermuda Society’s 33rd Annual Dinner. A dedicated forum, “Beyond Convergence,” focusing on insurance-linked securities (ILS), whose global market capacity Bermuda dominates, takes place today hosted by ILS Bermuda.
The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.
Director of Communications & PR
+1 441 292 7774
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future24.1.2020 17:00:00 EET | Press release
HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research. “In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk. The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scop
Conquest Invests in 5 Greenfield Onshore Wind Parks Totalizing 43MW in the Flanders Region24.1.2020 15:37:00 EET | Press release
Conquest, acting through the Conquest Sustainable Infrastructure fund, announced the transaction was closed after an exclusive agreement had been reached with ENGIE Electrabel. Conquest acquires 51% of a portfolio expected to provide 111 GWh per annum of renewable power representing the annual electricity consumption of about 32,000 Belgian homes from early 2021 onwards. The projects benefit from 15 to 20-year green certificates local remuneration schemes, and thus generate yearly secured revenues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005221/en/ Credit: Electrabel While the energy and digital transitions continue to drive the infrastructure sector, Conquest keeps building its diversified sustainable real asset portfolio in Western European markets. The success lies in years of collaboration and long-lasting partnerships with fellow industry experts who can notably facilitate access to new growth opportunities
Fluence Expands EMEA Footprint with Horticulture Partners in Papenburg, Germany24.1.2020 14:00:00 EET | Press release
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, announced today it is expanding its presence in the Emsland region of Germany through partnerships with growers and other horticulture specialists operating out of Papenburg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005109/en/ Friedrich Schulz’s 5.5 hectare farm—which grows herbs year-round in addition to lettuce, peppers and chives—utilizing VYPR 2p fixtures. (Photo: Business Wire) Given Papenburg’s decades-long history of attracting horticulture experts, Fluence’s innovative lighting solutions for horticulture are a natural fit for the region’s tomato, cucumber, leafy greens and herb growers. Forging connections with Papenburg’s horticultural leaders Elektro Evers, an engineering firm specializing in greenhouse technology, is Fluence’s exclusive systems integrator
HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EET | Press release
HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme
Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EET | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EET | Press release
Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom